Main Topics:
  • Therapeutic exploitation of DNA damage & repair pathways
  • New concepts to target RAS
  • Autophagy & Ubiquitin-dependent signaling
  • Targeting Transcription and MYC
  • Programmed cell death revisited
  • Tumor heterogeneity & cancer evolution
  • Precision Oncology: from bench to bedside
  • Targeting the Vulnerabilities of Cancer
Please note:
  • Abstract submission deadline: 30 November 2016
  • Please avoid special characters in title and text
  • Abstracts need to be submitted in English
  • Maximum number of characters: 2.500 including blanks
If you have any further questions,
please do not hesitate to contact:

Tina Streitberger
Kongress- und Kulturmanagement GmbH
Phone: +49 3643 2468-169
Email: tina.streitberger@kukm.de